Rhiannon E Evans1, Peter Craig2, Pat Hoddinott3, Hannah Littlecott4, Laurence Moore2, Simon Murphy4, Alicia O'Cathain5, Lisa Pfadenhauer6, Eva Rehfuess6, Jeremy Segrott7, Graham Moore4. 1. DECIPHer, School of Social Sciences, Cardiff University, Cardiff, UK EvansRE8@cardiff.ac.uk. 2. MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK. 3. Nursing, Midwifery and Allied Health Professions Research Unit (NMAHP RU), University of Stirling, Stirling, UK. 4. DECIPHer, School of Social Sciences, Cardiff University, Cardiff, UK. 5. Medical Care Research Unit, School of Health and Related Research (SHARR), University of Sheffield, Sheffield, UK. 6. Institute for Medical Informatics, Biometry and Epidemiology, Pettenkofer School of Public Health, LMU Munich, Munich, Germany. 7. DECIPHer, Centre for Trials Research (CTU), Cardiff University, Cardiff, UK.
Abstract
Entities:
Keywords:
adaptation; context; evaluation; intervention; population health
Rational models of evidence-informed policy have historically centred on an assumption that it is possible to identify ‘effective’ interventions, before recommending wider implementation. However, for population health interventions (which we define as inclusive of public health and health services), transferability to new contexts is often uncertain.1 Some interventions have demonstrated limited effectiveness, or even harm, when used elsewhere. For example, antenatal corticosteroids have reduced neonatal mortality among pregnant women at risk of preterm birth in high-income countries, but increased mortality and maternal infection in low-income and middle-income countries.2While definitions are contested, context can be defined as a set of active and unique characteristics and circumstances that interact with, modify, facilitate or constrain intervention delivery and effects. It includes geographical, epidemiological, sociocultural, socioeconomic, ethical, legal and political determinants.3 The argument that every context is unique and interventions cannot translate across them should not be overstated however. Some parenting interventions, for instance, have not successfully transferred, while others have been highly resilient to contextual variation, with minimal difference in effects between ‘home-grown’ and transported approaches.4There is increased recognition then of the need to consider context when making decisions about the transferability of evidence. Population health interventions are increasingly conceived as ‘events in systems’, which aim to modify aspect(s) of a pre-existing context, altering conditions that sustain suboptimal population health outcomes. Effects therefore may be shaped as much by changes to or displacement of prior features of the context, as by properties of the new intervention. Implementation may differ in a new context due to the complexity of the intervention components or ambiguity over its mechanisms, inhibiting high fidelity. Implementation failure may ensue if an intervention conflicts with entrenched cultural norms or requires resources that are not available. Even where implemented as intended, variation in effects may arise from differences in system starting points, with targeted outcomes driven and sustained by different underlying mechanisms.Assuming that a history of what has worked elsewhere can guarantee future success of similar action in a new time and place is therefore problematic. Equally, assuming effective approaches cannot be transported across contexts is contentious. A systematic understanding of the extant evidence base is important. Large and expensive re-evaluations may not be warranted if an intervention is acceptable and feasible in the new context, and there is robust evidence that the mechanisms targeted by the intervention are relevant. Moreover, there is a need to remain critical about whether purported failures to replicate effects genuinely reflect non-transferability, or are the consequence of the methodologies used in the evaluation in either the original or new context. For example, methods may have become more rigorous as the field develops or the evaluation moves from being conducted by intervention developers to independent investigators.5 When transferring ‘evidence-informed’ interventions to a new context, challenging decisions need to be made regarding (1) the need for adaptations to ensure that the intervention can be integrated into a new system, and (2) the level of uncertainty in the transferability of their effect and type of re-evaluation required.
What does ‘adaptation’ mean?
Although there has been limited conceptual development about what constitutes intervention adaptation, Stirman et al
6 broadly describe two domains. First are content modifications, which amend core intervention components. These may be surface-level (eg, enhancing cognitive understanding by amending language) or deep-level (eg, improving cultural fit by responding to the normative value system). Second are contextual modifications, which do not alter content. They may include adaptation to delivery strategies, agents, settings or target populations. The scope for adaptations will likely vary significantly across interventions; highly standardised, licensed interventions may not permit adaptations without permission from the developers. In other instances, interventions include a flexible set of processes that allow the form of components to change so long as the underlying functionality is maintained.There are numerous examples of adapted interventions, which often include but are not limited to (1) geographical: interventions transferred across countries (eg, HIV interventions from the USA to Uganda, which are shown to be as effective in increasing condom use and decreasing number of sexual partners)7; and (2) sociocultural: interventions replicated within the same geographical context with modifications for population subgroups (eg, mental health interventions for indigenous youth, which have demonstrated the need for implementation models responsive to the local community context of childcare services).8
The need for guidance on adapting population health interventions
In recent years, there has been an emergence of editorials and case studies on how to adapt population health interventions to new contexts. There is, however, no current overarching guidance. As such, current decision-making may be undertaken on an ad-hoc basis. Furthermore, there is a lack of consideration of the importance of describing context, with limited use of frameworks and methods for mapping system-level characteristics.3 9 Given the opaque manner in which decisions regarding adaptation are made, it is difficult to disentangle whether replication failures (or successes) in new contexts predominantly stem from intervention fit with the new context, implementation failure, adaptations that violate or enhance the intervention theory, or differences in the methodologies used to assess the transferability of effects. For example, an adapted version of the US-based Strengthening Families Program demonstrated no effect when introduced to Sweden.10 While attributed to differences between contexts, commentators argued that local adaptations had gone so far as to violate the intervention’s causal logic.11 New guidance is required to respond to these complexities and provide comprehensive and systematic decision-making tools.
Developing new guidance for the adaptation of complex population health interventions for new contexts
The Medical Research Council (MRC)-National Institute for Health Research (NIHR) Methodology Research Programme in the UK is currently supporting the development of guidance on the adaptation of evidence-informed population health interventions for new contexts. The authors of the present editorial are leading guidance development. Guidance will be developed through inter-related work packages, comprising (1) a systematic review of existing recommendations and a scoping review of interventions implemented and/or re-evaluated in new contexts; (2) qualitative interviews with research, policy and practice stakeholders; and (3) an international Delphi exercise to identify areas of consensus and key theoretical, methodological or substantive uncertainties that can inform the research agenda moving forward. This new guidance will support researchers, policymakers and practitioners in critically evaluating assertions that effects may or may not be contextually contingent, and how to draw on rigorous evidence to establish if adaptation is warranted. It will also support decision-making about the nature and extent of adaptations to be undertaken, how to describe the processes for undertaking adaptations, and the level of re-evaluation required to address uncertainties regarding transferability.Provision of criteria for assessing the appropriateness of adaptations will assist research funders, journal editors and peer reviewers in resourcing and disseminating the highest quality research. Uptake of guidance across stakeholders will help to overcome the current ad-hoc approach to practice within intervention adaptation. The guidance will build on existing MRC guidance, including guidance for developing and evaluating complex interventions12 and process evaluation.13 It will complement guidance currently in progress by some of the authors on intervention development (INDEX Study; IdentifyiNg and assessing different approaches to DEveloping compleX interventions), feasibility and pilot studies (GUEST Study; GUidance for Exploratory STudies of complexpublic health interventions), and the role of context within intervention development, evaluation and implementation.
Authors: Fernando Althabe; José M Belizán; Elizabeth M McClure; Jennifer Hemingway-Foday; Mabel Berrueta; Agustina Mazzoni; Alvaro Ciganda; Shivaprasad S Goudar; Bhalachandra S Kodkany; Niranjana S Mahantshetti; Sangappa M Dhaded; Geetanjali M Katageri; Mrityunjay C Metgud; Anjali M Joshi; Mrutyunjaya B Bellad; Narayan V Honnungar; Richard J Derman; Sarah Saleem; Omrana Pasha; Sumera Ali; Farid Hasnain; Robert L Goldenberg; Fabian Esamai; Paul Nyongesa; Silas Ayunga; Edward A Liechty; Ana L Garces; Lester Figueroa; K Michael Hambidge; Nancy F Krebs; Archana Patel; Anjali Bhandarkar; Manjushri Waikar; Patricia L Hibberd; Elwyn Chomba; Waldemar A Carlo; Angel Mwiche; Melody Chiwila; Albert Manasyan; Sayury Pineda; Sreelatha Meleth; Vanessa Thorsten; Kristen Stolka; Dennis D Wallace; Marion Koso-Thomas; Alan H Jobe; Pierre M Buekens Journal: Lancet Date: 2014-10-15 Impact factor: 79.321
Authors: Lisa M Pfadenhauer; Ansgar Gerhardus; Kati Mozygemba; Kristin Bakke Lysdahl; Andrew Booth; Bjørn Hofmann; Philip Wahlster; Stephanie Polus; Jacob Burns; Louise Brereton; Eva Rehfuess Journal: Implement Sci Date: 2017-02-15 Impact factor: 7.327
Authors: Jeremy Segrott; Jo Holliday; Heather Rothwell; David Foxcroft; Simon Murphy; Jonathan Scourfield; Kerenza Hood; Laurence Moore Journal: Eur J Public Health Date: 2014-04-09 Impact factor: 3.367
Authors: A Movsisyan; L Arnold; R Evans; B Hallingberg; G Moore; A O'Cathain; L M Pfadenhauer; J Segrott; E Rehfuess Journal: Implement Sci Date: 2019-12-17 Impact factor: 7.327
Authors: Maaike van der Wel; Doris van der Smissen; Sigrid Dierickx; Joachim Cohen; Peter Hudson; Aline De Vleminck; Lydia Tutt; David Scott; Silvia Di Leo; Caroline Moeller Arnfeldt; Catherine Jordan; Laurel Northouse; Judith Rietjens; Agnes van der Heide; Erica Witkamp Journal: Support Care Cancer Date: 2022-10-12 Impact factor: 3.359
Authors: Karolina Lobczowska; Anna Banik; Sarah Forberger; Krzysztof Kaczmarek; Thomas Kubiak; Agnieszka Neumann-Podczaska; Piotr Romaniuk; Marie Scheidmeir; Daniel A Scheller; Juergen M Steinacker; Janine Wendt; Marleen P M Bekker; Hajo Zeeb; Aleksandra Luszczynska Journal: BMC Public Health Date: 2022-05-26 Impact factor: 4.135
Authors: Graham Moore; Linda Cambon; Susan Michie; Pierre Arwidson; Grégory Ninot; Christine Ferron; Louise Potvin; Nadir Kellou; Julie Charlesworth; François Alla Journal: Trials Date: 2019-06-11 Impact factor: 2.279
Authors: Laura Lamming; Eileen McDonach; Mohammed A Mohammed; John Stoves; Andy J Lewington; Russell Roberts; Yohan Samarasinghe; Nikunj Shah; Richard J Fluck; Natalie Jackson; Melanie Johnson; Carol Jones; Nicholas M Selby Journal: PLoS One Date: 2019-09-20 Impact factor: 3.240
Authors: Lauren Copeland; Hannah Littlecott; Danielle Couturiaux; Pat Hoddinott; Jeremy Segrott; Simon Murphy; Graham Moore; Rhiannon Evans Journal: PLoS One Date: 2021-07-09 Impact factor: 3.752
Authors: Frida Svedin; Anders Brantnell; Paul Farrand; Oscar Blomberg; Chelsea Coumoundouros; Louise von Essen; Anna Cristina Åberg; Joanne Woodford Journal: BMJ Open Date: 2021-07-16 Impact factor: 2.692